Pretreatment and serial plasma assessments of EGFR mutations in NSCLC patients treated with rociletinib (CO-1686) Goldman, J. W., Karlovich, C., Mann, E., Rolfe, L., Matheny, S., Despain, D., Angenendt, P., Stamm, C., Wakelee, H. A., Soria, J., Solomon, B., Camidge, D. R., Dziadziuszko, R., Horn, L., Gadgeel, S., Raponi, M., Allen, A. R., Sequist, L. V. AMER ASSOC CANCER RESEARCH. 2015

View details for DOI 10.1158/1538-7445.AM2015-927

View details for Web of Science ID 000371578501378